Theravance Biopharma Inc (TBPH)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione

Theravance Biopharma Inc Azioni (TBPH) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	17.43% 14.50	17.57	15.69	13.75	10.42
Operating Expenses	8.00% 25.71	23.80	24.45	29.87	35.33
Interest Income/Expense	0.96% 0.629	0.623	0.609	0.568	0.55
Benefits Costs and Expenses	4.49% 24.91	26.07	24.64	29.39	32.51
Costs And Expenses	4.49% 24.91	26.07	24.64	29.39	32.51
Operating Income/Loss	79.60% -11.21	-6.24	-8.76	-16.12	-24.91
Income/Loss From Continuing Operations Before Tax	22.23% -10.40	-8.51	-7.583	-14.19	-22.48
Income Tax Expense/Benefit, Deferred	-0.513	-	-	-	-
Income Tax Expense/Benefit	63.88% 1.262	3.494	1.367	1.458	-0.395
Income/Loss From Continuing Operations After Tax	37.06% -11.66	-8.51	-8.95	-15.64	-22.09
Net Income/Loss	37.06% -11.66	-8.51	-8.95	-15.64	-22.09
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	2,534% 48.28	-1.984	52.36	56.68	62.93
Diluted Average Shares	2,534% 48.28	-1.984	52.36	56.68	62.93
Basic Earnings Per Share	41.18% -0.24	-0.17	-0.17	-0.28	-0.35
Diluted Earnings Per Share	41.18% -0.24	-0.17	-0.17	-0.28	-0.35
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

SMMT

$17.89

1.76%

GMAB

$20.77

1.19%

MRNA

$39.38

1.87%

UTHR

$357.64

0.64%

BGNE

$183.81

1.06%

BNTX

$112.58

1.20%